Cannabis Investing 2024: 3 Top Marijuana Stocks To Watch
Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum
Top Marijuana Stocks To Follow In 2024

3 Marijuana Stocks That Could Worth Your Time And Money

The post Top Marijuana Stocks To Follow In 2024 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
The DEA has rescinded a 2023 directive which previously ordered a pharmaceutical company to shutter operations after they were found to have helped perpetuate the nationwide opioid crisis. Morris & Dickson, a multi-billion dollar Big Pharma giant which has been in business since 1841 will be permitted to continue... Read more
An Iowa legislative panel this week approved a bill that sets limits on consumable hemp products sold in the state. The measure, House Study Bill 665, was approved on Wednesday by the House Public Safety Subcommittee by a vote of 2-0.  The bill, which was submitted to the state... Read more
Tuesday, Sen. Bernie Sanders (I-Vermont) issued a report slamming the U.S. prices of drugs and executive pay of three major drug manufacturers—Johnson & Johnson (J&J), Merck, and Bristol Myers Squibb—just before a Feb. 8 hearing. Thursday the CEO’s of all three drug manufacturers had to appear before a hearing... Read more
Best Cannabis REITs for Investors Watchlist In 2024
Seventeen percent of Americans aged 18 and older reported smoking pot in 2023. That is largely unchanged from Gallup’s most recent findings on the matter. In 2022, 16% of American adults said they smoke marijuana.  But the 17% figure represents a marked increase since 2013, when Gallup first added... Read more
A strange new type of star referred to by scientists as an “old smoker” has been discovered after a years-long astronomical study.  According to four different studies recently published in Monthly Notices of the Royal Astronomical Society, these recently discovered stellar objects are essentially really large and very old... Read more
This year is shaping up to potentially be one of the most historic when it comes to cannabis, as U.S. advocates and consumers alike await the final decision from the Drug Enforcement Administration (DEA) on whether it will reschedule cannabis from a Schedule I to Schedule III controlled substance.... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )